Search research articles
Contact Us
Filters
Showing results (181-190 of 205) with videos related to
Page
of 21
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
July 21, 2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
Trine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 3, 2022
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up
Trine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Blood Advances
|
August 5, 2025
Safety and Efficacy of Daratumumab in Immune Thrombocytopenia
Galina Tsykunova, Pål Andre Holme, Hoa Thi Thyuet Tran, et al.
Thrombosis Research
|
June 16, 2023
Arterial events in cancer patients treated with apixaban for venous thrombosis
Trine-Lise Larsen, Marte Svalastoga, Jorunn Brekke, et al.
American Journal of Hematology
|
April 6, 2026
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial
Nichola Cooper, Catherine M Broome, Yoshitaka Miyakawa, et al.
Research and Practice in Thrombosis and Haemostasis
|
November 30, 2022
SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people
Lamya Garabet, Anna Eriksson, Eirik Tjønnfjord, et al.
Hematology (Amsterdam, Netherlands)
|
September 18, 2025
Iraqi consensus recommendations for the diagnosis and management of immune thrombocytopenia
Ahmed Mjali, Bassam Francis Matti, Waleed Ghanima, et al.
Haematologica
|
June 26, 2025
Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registries
Guillaume Moulis, Frederick Chen, Giuseppe Carli, et al.
Thrombosis Research
|
August 22, 2021
Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome
Gudula J A M Boon, Steffi M J Janssen, Stefano Barco, et al.
Blood Advances
|
November 27, 2019
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan, Donald M Arnold, James B Bussel, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 205) with videos related to
Sort By:
Page
of 21
Journal of Thrombosis and Haemostasis : JTH
|
July 21, 2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
Trine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 3, 2022
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up
Trine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Blood Advances
|
August 5, 2025
Safety and Efficacy of Daratumumab in Immune Thrombocytopenia
Galina Tsykunova, Pål Andre Holme, Hoa Thi Thyuet Tran, et al.
Thrombosis Research
|
June 16, 2023
Arterial events in cancer patients treated with apixaban for venous thrombosis
Trine-Lise Larsen, Marte Svalastoga, Jorunn Brekke, et al.
American Journal of Hematology
|
April 6, 2026
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial
Nichola Cooper, Catherine M Broome, Yoshitaka Miyakawa, et al.
Research and Practice in Thrombosis and Haemostasis
|
November 30, 2022
SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people
Lamya Garabet, Anna Eriksson, Eirik Tjønnfjord, et al.
Hematology (Amsterdam, Netherlands)
|
September 18, 2025
Iraqi consensus recommendations for the diagnosis and management of immune thrombocytopenia
Ahmed Mjali, Bassam Francis Matti, Waleed Ghanima, et al.
Haematologica
|
June 26, 2025
Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registries
Guillaume Moulis, Frederick Chen, Giuseppe Carli, et al.
Thrombosis Research
|
August 22, 2021
Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome
Gudula J A M Boon, Steffi M J Janssen, Stefano Barco, et al.
Blood Advances
|
November 27, 2019
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan, Donald M Arnold, James B Bussel, et al.
Page
of 21